<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04057235</url>
  </required_header>
  <id_info>
    <org_study_id>CP-00001</org_study_id>
    <nct_id>NCT04057235</nct_id>
  </id_info>
  <brief_title>Retrospective Review of Integrity Implants FlareHawk® for Lumbar Fusion</brief_title>
  <official_title>Transforaminal/Posterior Lumbar Interbody Fusion With the FlareHawk® Expandable Interbody Fusion Device: A Retrospective Chart Review Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Integrity Implants Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Integrity Implants Inc.</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a retrospective clinical study (chart review) of patients who have previously
      undergone Transforaminal Lumbar Interbody Fusion or Posterior Lumbar Interbody Fusion surgery
      with the FlareHawk expandable interbody fusion cage at one or two contiguous levels.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to evaluate the clinical outcomes of patients who have undergone
      a Transforaminal Lumbar Interbody Fusion (TLIF) or Posterior Lumbar Interbody Fusion (PLIF)
      procedure with a FlareHawk expandable interbody fusion cage(s) to assess the device's
      performance and safety when used in accordance with its intended use. The primary hypothesis
      is that study subjects who received the FlareHawk expandable cage(s) through a TLIF or PLIF
      procedure experienced fusion by 12 months (+/- 3 mo) follow-up, with improvements in clinical
      outcomes related to pain and/or disability compared to pre-operative scores. Further, the
      subjects are hypothesized to have not experienced any unforeseen device- or procedure-related
      adverse events.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 23, 2019</start_date>
  <completion_date type="Actual">December 18, 2019</completion_date>
  <primary_completion_date type="Actual">December 13, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Radiographic Arthrodesis</measure>
    <time_frame>12 months +/- 3 months</time_frame>
    <description>Proportion of participants with radiographic arthrodesis at 12 months +/- 3 months as determined using plain radiographic images with assessment based on the Bridwell-Lenke grading system [Bridwell and Lenke et al, 1995].</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Visual Analog Scale (VAS) for Leg Pain From Preoperative Baseline to Last Available Follow-up</measure>
    <time_frame>From baseline to last available follow-up, with an average follow-up of 4.6 ± 4.4 months (range: 0.5-20.5 mo)</time_frame>
    <description>Visual analog scale for measuring pain intensity related to leg pain. The scale is anchored by &quot;no pain&quot; (score of 0) and &quot;pain as bad as it could be&quot; or &quot;worst imaginable pain&quot; (score of 10).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Visual Analog Scale (VAS) for Back Pain From Preoperative Baseline to Last Available Follow-up</measure>
    <time_frame>From baseline to last available follow-up, with an average follow-up of 4.4 ± 4.3 months (range: 0.5-20.5 mo)</time_frame>
    <description>Visual analog scale for measuring pain intensity related to back pain. The scale is anchored by &quot;no pain&quot; (score of 0) and &quot;pain as bad as it could be&quot; or &quot;worst imaginable pain&quot; (score of 10).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Oswestry Disability Index (ODI) From Baseline to Last Available Follow-up</measure>
    <time_frame>From baseline to last available follow-up, with an average follow-up of 4.4 ± 3.8 months (range: 0.5-20.5 mo)</time_frame>
    <description>ODI is used to quantify disability related to lower back pain. The final score/index ranges from 0-100. A score of 0-20 reflects minimal disability, 21-40 moderate disability, 41-60 severe disability, 61-80 crippled, and 81-100 bed-bound.</description>
  </secondary_outcome>
  <enrollment type="Actual">129</enrollment>
  <condition>Degenerative Disc Disease</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>FlareHawk Interbody Fusion System</intervention_name>
    <description>Expandable lumbar intervertebral body fusion device</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        A total of at least 100 patients from at least three sites will be enrolled based on
        inclusion/exclusion criteria. The retrospective chart review will include the full
        consecutive series of patients who received TLIF or PLIF surgery using the FlareHawk
        expandable interbody fusion cage between December 1, 2017, and May 31, 2018. Subjects from
        that consecutive series will be included in the study based on the pre-defined inclusion
        and exclusion criteria. All subjects will have been diagnosed with degenerative disc
        disease of the lumbar spine that required lumbar interbody fusion procedure at one or two
        levels as per the opinion of the treating surgeon. All subjects who meet the inclusion
        criteria and do not meet any of the exclusion criteria will be included in the study
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        To be a part of this study, the subject must:

          1. Have been at least 18 years of age and skeletally mature at the time of surgery

          2. Have had clinical and radiological evidence of degenerative disc disease of the lumbar
             spine

          3. Have been treated with PLIF or TLIF surgery using the FlareHawk expandable interbody
             cage(s) at 1 or 2 contiguous levels from L2 to S1

          4. Have been treated using the FlareHawk expandable interbody fusion cage, according to
             the approved labeling, between December 1, 2017, and May 31, 2018

        Exclusion Criteria:

        Subjects must not meet any of the following exclusion criteria to be included in the study:

          1. Have a history of fusion surgery at the study level(s) prior to treatment with the
             FlareHawk device(s)

          2. Have had spondylolisthesis unable to be reduced to grade 1 as part of the surgical
             procedure

          3. Have had surgery with the FlareHawk device(s) at more than 2 levels

          4. Have had surgery with the FlareHawk device(s) at levels outside the range of L2 to S1

          5. Have been treated with any bone grafting material other than autogenous or allogenic
             bone graft in the FlareHawk device(s) and surrounding disc space

          6. Have any contraindications listed in the approved labeling
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Domagoj Coric, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Carolina Neurosurgery &amp; Spine Associates, Charlotte, NC</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Chatham Orthopaedic Associates</name>
      <address>
        <city>Savannah</city>
        <state>Georgia</state>
        <zip>31405</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Carolina Neurosurgery &amp; Spine Associates</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28204</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northeast Ohio Spine Center</name>
      <address>
        <city>Akron</city>
        <state>Ohio</state>
        <zip>44333</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>August 13, 2019</study_first_submitted>
  <study_first_submitted_qc>August 13, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 15, 2019</study_first_posted>
  <results_first_submitted>February 14, 2020</results_first_submitted>
  <results_first_submitted_qc>April 1, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">April 14, 2020</results_first_posted>
  <last_update_submitted>April 13, 2020</last_update_submitted>
  <last_update_submitted_qc>April 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 21, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Intervertebral Disc Degeneration</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>November 15, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/35/NCT04057235/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Single Retrospective Study Arm</title>
          <description>Participants who previously underwent Transforaminal Lumbar Interbody Fusion (TLIF) or Posterior Lumbar Interbody Fusion (PLIF) surgery with the FlareHawk® expandable interbody fusion device.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="129"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Had Radiographic Data</title>
              <participants_list>
                <participants group_id="P1" count="58"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Had ODI Data</title>
              <participants_list>
                <participants group_id="P1" count="43"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Had VAS Back Data</title>
              <participants_list>
                <participants group_id="P1" count="45"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Had VAS Leg Data</title>
              <participants_list>
                <participants group_id="P1" count="45"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="129">All 129 participants had data for at least one of the primary/secondary outcomes or adverse events</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Single Retrospective Study Arm</title>
          <description>Participants who previously underwent TLIF or PLIF surgery with the FlareHawk® expandable interbody fusion device.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="129"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="129"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="60.5" spread="12.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <population>Gender of one subject not recorded in patient chart</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="128"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="72"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="129"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="129"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body Mass Index (BMI)</title>
          <units>kg/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="129"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="31.3" spread="7.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Smoking Status</title>
          <population>Smoking status not available for 4 patients</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="125"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Non-smoker</title>
                  <measurement_list>
                    <measurement group_id="B1" value="73"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Active smoker</title>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Previous smoker</title>
                  <measurement_list>
                    <measurement group_id="B1" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Co-Morbidities</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Hypertension</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="129"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Diabetes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="129"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Obesity (BMI &gt;= 30)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="129"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hypercholesterolemia</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="129"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Coronary Heart Disease</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="129"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hypothyroidism</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="129"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Active or History of Cancer</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="129"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Baseline VAS Leg Pain</title>
          <description>Visual Analog Scale for Leg Pain; Scale = 0-10; 0 = No Pain; 10 = Worst Pain</description>
          <population>Baseline VAS Leg Pain score was not recorded in patient chart for some subjects</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="53"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6.8" spread="2.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Baseline VAS Back Pain</title>
          <description>Visual Analog Scale for Back Pain; Scale = 0-10; 0 = No Pain; 10 = Worst Pain</description>
          <population>Baseline VAS Back Pain score was not recorded in patient chart for some subjects</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="57"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7.7" spread="2.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Baseline ODI</title>
          <description>Oswestry Disability Index; Scale = 0-100
0–20: Minimal disability 21–40: Moderate Disability 41–60: Severe Disability 61–80: Crippling back pain 81–100: Bed-bound</description>
          <population>Baseline ODI score was not recorded in patient chart for some subjects</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="56"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="55.0" spread="17.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Radiographic Arthrodesis</title>
        <description>Proportion of participants with radiographic arthrodesis at 12 months +/- 3 months as determined using plain radiographic images with assessment based on the Bridwell-Lenke grading system [Bridwell and Lenke et al, 1995].</description>
        <time_frame>12 months +/- 3 months</time_frame>
        <population>Participants who had radiographs available at 12 months follow-up</population>
        <group_list>
          <group group_id="O1">
            <title>Single Retrospective Study Arm</title>
            <description>Participants who previously underwent TLIF or PLIF surgery with the FlareHawk® expandable interbody fusion device.</description>
          </group>
        </group_list>
        <measure>
          <title>Radiographic Arthrodesis</title>
          <description>Proportion of participants with radiographic arthrodesis at 12 months +/- 3 months as determined using plain radiographic images with assessment based on the Bridwell-Lenke grading system [Bridwell and Lenke et al, 1995].</description>
          <population>Participants who had radiographs available at 12 months follow-up</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="58"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Visual Analog Scale (VAS) for Leg Pain From Preoperative Baseline to Last Available Follow-up</title>
        <description>Visual analog scale for measuring pain intensity related to leg pain. The scale is anchored by &quot;no pain&quot; (score of 0) and &quot;pain as bad as it could be&quot; or &quot;worst imaginable pain&quot; (score of 10).</description>
        <time_frame>From baseline to last available follow-up, with an average follow-up of 4.6 ± 4.4 months (range: 0.5-20.5 mo)</time_frame>
        <population>Participants who had VAS Leg data available at both baseline and follow-up</population>
        <group_list>
          <group group_id="O1">
            <title>Single Retrospective Study Arm</title>
            <description>Participants who previously underwent TLIF or PLIF surgery with the FlareHawk® expandable interbody fusion device.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Visual Analog Scale (VAS) for Leg Pain From Preoperative Baseline to Last Available Follow-up</title>
          <description>Visual analog scale for measuring pain intensity related to leg pain. The scale is anchored by &quot;no pain&quot; (score of 0) and &quot;pain as bad as it could be&quot; or &quot;worst imaginable pain&quot; (score of 10).</description>
          <population>Participants who had VAS Leg data available at both baseline and follow-up</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.9" spread="3.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Visual Analog Scale (VAS) for Back Pain From Preoperative Baseline to Last Available Follow-up</title>
        <description>Visual analog scale for measuring pain intensity related to back pain. The scale is anchored by &quot;no pain&quot; (score of 0) and &quot;pain as bad as it could be&quot; or &quot;worst imaginable pain&quot; (score of 10).</description>
        <time_frame>From baseline to last available follow-up, with an average follow-up of 4.4 ± 4.3 months (range: 0.5-20.5 mo)</time_frame>
        <population>Participants who had VAS Back data at both baseline and follow-up</population>
        <group_list>
          <group group_id="O1">
            <title>Single Retrospective Study Arm</title>
            <description>Participants who previously underwent TLIF or PLIF surgery with the FlareHawk® expandable interbody fusion device.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Visual Analog Scale (VAS) for Back Pain From Preoperative Baseline to Last Available Follow-up</title>
          <description>Visual analog scale for measuring pain intensity related to back pain. The scale is anchored by &quot;no pain&quot; (score of 0) and &quot;pain as bad as it could be&quot; or &quot;worst imaginable pain&quot; (score of 10).</description>
          <population>Participants who had VAS Back data at both baseline and follow-up</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.4" spread="2.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Oswestry Disability Index (ODI) From Baseline to Last Available Follow-up</title>
        <description>ODI is used to quantify disability related to lower back pain. The final score/index ranges from 0-100. A score of 0-20 reflects minimal disability, 21-40 moderate disability, 41-60 severe disability, 61-80 crippled, and 81-100 bed-bound.</description>
        <time_frame>From baseline to last available follow-up, with an average follow-up of 4.4 ± 3.8 months (range: 0.5-20.5 mo)</time_frame>
        <population>Participants with both baseline and follow-up ODI data</population>
        <group_list>
          <group group_id="O1">
            <title>Single Retrospective Study Arm</title>
            <description>Participants who previously underwent TLIF or PLIF surgery with the FlareHawk® expandable interbody fusion device.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Oswestry Disability Index (ODI) From Baseline to Last Available Follow-up</title>
          <description>ODI is used to quantify disability related to lower back pain. The final score/index ranges from 0-100. A score of 0-20 reflects minimal disability, 21-40 moderate disability, 41-60 severe disability, 61-80 crippled, and 81-100 bed-bound.</description>
          <population>Participants with both baseline and follow-up ODI data</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="43"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-14.6" spread="19.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse event data were collected at the time of surgery (intraoperative adverse events) and through last patient follow-up, with an average follow-up time of 8.0 ± 4.9 months (range: 0.5–20.5 mo).</time_frame>
      <desc>Adverse Events were not monitored/assessed with regard to specific Adverse Event Terms.</desc>
      <group_list>
        <group group_id="E1">
          <title>Single Retrospective Study Arm</title>
          <description>Participants who previously underwent TLIF or PLIF surgery with the FlareHawk® expandable interbody fusion device.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="129"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="129"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Subsequent surgical intervention</sub_title>
                <description>Revision surgery for failed supplemental instrumentation (pedicle screws or rods; not FlareHawk device) or adjacent segment disease. Adverse Events were not monitored/assessed with regard to specific Adverse Event Terms.</description>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="129"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="19" subjects_at_risk="129"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Mild to Moderate Adverse Events</sub_title>
                <description>Other mild to moderate adverse events commonly associated with lumbar interbody fusion surgery. Adverse Events were not monitored/assessed with regard to specific Adverse Event Terms.</description>
                <counts group_id="E1" events="22" subjects_affected="19" subjects_at_risk="129"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>This was a retrospective study of patient chart data. No data was prospectively collected as part of this study. Therefore, follow-up data is limited among the overall cohort.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Lauren Kamer, Senior Director of Regulatory and Clinical Affairs</name_or_title>
      <organization>Integrity Implants Inc</organization>
      <phone>+1.561.529.3861</phone>
      <email>lkamer@integrityimplants.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

